BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19094062)

  • 1. Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors.
    Krenz A; Falkenburger BH; Gerhardt E; Drinkut A; Schulz JB
    J Neurochem; 2009 Jan; 108(1):139-46. PubMed ID: 19094062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synphilin-1 transgenic mice exhibit mild motor impairments.
    Jin HG; Yamashita H; Nakamura T; Fukuba H; Takahashi T; Hiji M; Kohriyama T; Matsumoto M
    Neurosci Lett; 2008 Nov; 445(1):12-7. PubMed ID: 18782602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.
    Casadei N; Pöhler AM; Tomás-Zapico C; Torres-Peraza J; Schwedhelm I; Witz A; Zamolo I; De Heer R; Spruijt B; Noldus LP; Klucken J; Lucas JJ; Kahle PJ; Krüger R; Riess O; Nuber S
    Hum Mol Genet; 2014 Feb; 23(3):767-81. PubMed ID: 24064336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of synphilin-1 in synaptic function and protein degradation.
    Krüger R
    Cell Tissue Res; 2004 Oct; 318(1):195-9. PubMed ID: 15322916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.
    Matsuoka Y; Vila M; Lincoln S; McCormack A; Picciano M; LaFrancois J; Yu X; Dickson D; Langston WJ; McGowan E; Farrer M; Hardy J; Duff K; Przedborski S; Di Monte DA
    Neurobiol Dis; 2001 Jun; 8(3):535-9. PubMed ID: 11442360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.
    Marx FP; Holzmann C; Strauss KM; Li L; Eberhardt O; Gerhardt E; Cookson MR; Hernandez D; Farrer MJ; Kachergus J; Engelender S; Ross CA; Berger K; Schöls L; Schulz JB; Riess O; Krüger R
    Hum Mol Genet; 2003 Jun; 12(11):1223-31. PubMed ID: 12761037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
    Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
    Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
    Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.
    Song DD; Shults CW; Sisk A; Rockenstein E; Masliah E
    Exp Neurol; 2004 Apr; 186(2):158-72. PubMed ID: 15026254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
    Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
    Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray expression analysis reveals genetic pathways implicated in C621 synphilin-1-mediated toxicity.
    Bonin M; Marx FP; Kautzmann S; Riess O; Krüger R
    J Neural Transm (Vienna); 2008 Jul; 115(7):941-58. PubMed ID: 18292964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions.
    Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F
    J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
    Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synphilin in normal human brains and in synucleinopathies: studies with new antibodies.
    Murray IJ; Medford MA; Guan HP; Rueter SM; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2003 Feb; 105(2):177-84. PubMed ID: 12536229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast.
    Swinnen E; Büttner S; Outeiro TF; Galas MC; Madeo F; Winderickx J; Franssens V
    Biochem Soc Trans; 2011 Oct; 39(5):1476-81. PubMed ID: 21936837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.